Cytokine detection and measurement is important as elevated concentrations of cytokines may indicate the activation of cytokine signaling pathways associated with inflammation or disease progression. Consequently, these proteins are widely used as biomarkers to characterize the immune function, understand and predict disease, and monitor effects of treatment. (Catalfamo et al. 2012) Measurement sensitivity is always an issue for cytokines because they are released into the extracellular milieu resulting in pM concentration range. (Schenk et al. 2001) In addition to low concentrations, it is difficult to measure physiological concentrations of cytokines accurately and reproducibly due to some challenges ( Figure 1 ) such as significant interference from heterophilic antibodies, (Bolstad et al. 2013 ) the rheumatoid factors, (Bartels et al. 2011 ) and specific or non-specific cytokine binding proteins, (Whicher and Evans 1990 ) and an extremely dynamic, transient cytokine secretion process. (Kulbe et al. 2012 ) Figure 1 The scheme showing challenges, requirements and strategies for cytokine detection. The challenges include complicated cytokine network, large number of different cytokines, low concentration of cytokines, and rapid dynamics of cytokine expression. Correspondingly, cytokine detection methods requires multiplex capability, enhancement in selectivity and sensitivity, and real time measurement. The strategies to address these challenges are proposed to be application of sensor arrays, monoclonal antibodies, nanomaterials, multifluidic system, and et al.
The most common approach for cytokine quantification is based on the idea of an immunoassay. Specific techniques include traditional ELISA assays, (Chiswick et al. 2012 ) enzyme-linked immunosorbent spot (ELIspot) assays, (Cox et al. 2006) antibody array assays (Schröder et al. 2010 ) and bead-based assays (Won et al. 2012 ).
Traditional ELISA assays are reliable, but they are not rapid (6 h) and usually require a relatively large sample volume (100 µL). Generally speaking, all these assays require a long sample preparation time (> 6 h), and multiplexed approaches require a high level of complexity in the sample labeling. Some assay types require specialized flow cytometry infrastructure, and all are unable to monitor the cytokines in real time or in a dynamic manner. These limitations are the driving force for researchers to develop sensitive, selective, and rapid real time cytokine analysis platforms for comprehensive characterization and quantitative analysis of cytokines released in both healthy and pathological conditions. The purpose of this review is to discuss recent advances in development of analytical approaches especially immunosensors for cytokine detection focusing on designing sensing interfaces to achieve high sensitivity, selectivity, stability, simplicity, and no sample matrix effects. This work is not intended to be a comprehensive review on cytokine detection, as several excellent reviews of analytical methods for measurement of cytokine proteins have been recently published. Rusling et al. 2010; Stenken and Poschenrieder 2015) Rather, we will examine the latest trends in cytokine detection based on immunosensing.
Principles of immunosensors
Immunosensors are immunoreaction-based affinity biosensors, which use The interaction of an antibody (Ab) with an antigen (Ag) forms the basis of immunosensors, which defines both specificity and detection limit of an immunosensor. (Mehrvar et al. 2000) The Ab-Ag interaction is characterized with an association and a dissociation reaction rate constant, ka and kd respectively.
The ultimate detection limit of an immunoassay is determined by the antibody-antigen binding constant. (Moal and Bates 2012) The greater the binding constant of the antibody, the lower detection limit can be achieved. The affinity constant KA, which varies in strength from 10 4 to 10 15 M -1 (typically of the order of 10 8 to 10 12 M -1 ) depending on the nature of antigens and binding affinity of the corresponding antibodies, can be described by: [Ag] and [Ab-Ag] are molar concentrations of antibody, antigen and antibody-antigen complex in solution, respectively. The transduction of such antibody and antigen biorecognition events either requires labels, commonly used in a myriad of immunoassay formats, or a method which can directly detect the change that occurs at the sensing interface. Most immunosensor devices reported to date perform indirect measurements by using labels such as enzymes, (Malhotra et al. 2012 ) fluorescent (Zhao et al. 2011 ) and chemiluminescent (Sardesai et al. 2013) probes that convert affinity signal into a measurable response. Although indirect immunosensors are highly sensitive due to analytical characteristics of the label applied, the non-specific binding is a continuing problem. (Huang et al. 2015a ) Therefore special methodologies to resist non-specific protein adsorption are critically required for sensing analytes in a complex matrix sample, such as blood or urine. Consequently, despite decades of effort it is still challenging to design a sensing interface with properties of high sensitivity, high selectivity, high stability, simplicity, and no matrix sample effect.
The desire to have all of these properties simultaneously present at the same sensing interface drives research as well as commercial developments.
Immunosensors for cytokine detection
Given that cytokines are universal biomarkers implicated in the functioning of immune and other physiological processes, it is not surprising that cytokine detection is one of the hottest topics in immunosensing. However, publications reporting immunosensors for cytokine detection are limited due to some analytical challenges with cytokine detection (Figure 1 ). Table S1 lists representative immunosensors for cytokine detection based on different signalling strategies such as fluorescence immunoassay (FI), surface plasmon resonance detection (SPR), electrochemical-based methods (EC), silicon photonic micro-ring resonators (MR) and other methods. This section aims to generally describe the advantages and limitations with respect to each signal detection strategy, and a more detailed discussion of each of these different signalling strategies is reported elsewhere. (Stenken and Poschenrieder 2015) 
Fluorescence based immunsensing
The fluorescence immunoassay (FI) is a method which monitors Ab-Ag binding based on changes in fluorescence signal (Figure 2) , and recent publications outlining the principle of FI are summarized. ) It represents the most widely studied methodology for cytokine detection due to its high sensitivity. In addition, fluorescent methods are simple, diverse and non-destructive, and can be integrated into microfluidic devices for cytokine monitoring in real time. (Zhao et al. 2011) The wide abundance of different fluorescent labels makes FI technology capable of multiplexing.
However, photobleaching of fluorescent dye labels and spectral overlap of reporter dyes may limit the degree of multiplexing, while luminescent background of sample matrix can interfere with the measurement and/or interpretation of results. (Campos et al. 2011) The detection limit of fluorescence based immunosensing ranges from fg mL -1 to ng mL -1 , so it is generally sufficient for many cytokines in physiological conditions.
Surface plasmon resonance based immunsensing
SPR is an important tool to monitor interactions between biomolecules. ( detection are attractive due to high sensitivity (~2 pg mL -1 ) (Jeong et al. 2013 ) and the absence of labels. However, a common challenge with SPR-based sensors is the issue of overcoming signals produced via non-specific binding events on the sensor.
Electrochemical based immunsensing
Electrochemical methods (EC) have been used for protein detection by immunoassays for quite some time. (Luo and Davis 2013) In this approach, the Ab-Ag bioreconginition is probed based on the electrochemical signal from redox probes Table S1 we can see electrochemical assays achieve comparable detection limit to FL but with shorter analysis time. The scope of using EC for multiplexing is limited due to limited availability of redox probes for reporting the electrochemical signal. (Ahn et al. 2013) and arrayed imaging reflectometry (AIR) (Carter et al. 2011) are recently developed for cytokine detection with acceptable sensitivity (less than 10 pg mL -1 ).
Microring
All these reported approaches aim to address one or more of detection challenges associated with cytokine detection: sensitivity (~10 pg mL -1 or better), selectivity, multiplexing, and real-time detection. Achieving high stability, simplicity, shorter 
2013)

Using aptamers as recognition reagents
Aptamers are single strands of either DNA or RNA oligonucleotides that can be used to bind different analytes with higher selectivity and affinity than antibodies, and they are typically produced by selection from large combinatorial libraries. (Yüce et al. 2015) Using aptamers as recognition reagents in biosensors has been reviewed in references. (Deng et al. 2014; Iliuk et al. 2011; Kim et al. 2016) The current active research on aptamers as alternative molecular recognition agents and possible substitutes for antibodies, has further widened the application of immunosensing in chemical analysis. (Famulok and Mayer 2011) In particular, aptamers can be readily site-specifically modified during chemical or enzymatic synthesis to incorporate particular reporters, linkers, or other moieties. Also, aptamer secondary structures can be engineered to undergo analyte-dependent conformational changes, which opens up a wealth of possible signal transduction schemes, irrespective of whether the detection modality is optical, electrochemical, or mass based. Another advantage of using aptamers for specific target capture is their higher stability compared to antibodies.
Consequently they can be used in harsh protein denaturing conditions. ( 
Prevention of non-specific protein binding
Modification of sensing interfaces with molecules being able to resist non-specific adsorption is another efficient way to improve sensitivity and selectivity of the immunosensing system. with femtomolar sensitivity for cytokines in serum and blood. (Hucknall et al. 2009) The nonfouling polymer brushes can efficiently resist protein adsorption from solution, and eliminate background non-specific signals in microarrays and lead to detection limits as low as 100 fg mL -1 (5 fM) in serum and 15 fM in whole blood. It is critically important to introduce molecules to sensing interface which can resist non-specific protein adsorption as the low detection limit depends on it. However, the problem of resisting non-specific protein adsorption has not yet been fully resolved.
The management of non-specific binding remains one of the core challenges in cytokine analysis, and exploring reliable approaches to control non-specific protein adsorption needs further research. 
Strategies for improving sensitivity
Numerous strategies attempt to achieve sensitivity improvement through signal amplification, including nanomaterial-based approaches, (Lei and Ju 2012) DNA-labeling techniques, (Hocek and Fojta 2011) electrochemiluminescence, ) and in situ hybridization methods. (Urbanek et al. 2015) Here we only focus on techniques for improving sensitivity of cytokine detection based on signal amplification taking place on sensing interfaces.
Amplified transduction with nanomaterials
Generally, immunoreagents (such as antibodies) are immobilized on a transducer while the analyte (antigen) is measured through a label conjugated with one of the immunoreagents. (Pei et al. 2013 ) Nanomaterial-based fluorescent, luminescent, refractive index, light scattering and/or colorimetric labels have been integrated into analytical chemistry and used by large number of novel sensing techniques. (Scida et al. 2011; Shen et al. 2014 ) Nanomaterial-based sensing platforms can provide advantages over traditional approaches in terms of sensitivity, stability, and capability for multiplexing and real time detection.(Chen and Chatterjee 2013) Importantly, nanomaterials can be functionalised to improve their ability to bind in a designated location, such as the surface of a cytokine secreting cell and signal the presence of proteins. They can be coated with antibodies, antigens, aptamers, enzymes specific to a protein, or receptors overexpressed on cell surface, or specific to cancer biomarkers.
These nanomaterials can accommodate a large number of such targeting moieties due to high area-to-volume ratio, which makes nanomaterials attractive in biosensors. These examples above show enormous scope of nanomaterials offering for immunosensing of cytokines in regards to signal amplification. There is a similar scope to covalently attach multifunctional components (biomolecules and anti-fouling molecules) onto nanomaterials without steric hindrance and exploitation of these ideas for cytokine detection is likely to lead to further advances in sensitivity.
Microsphere-based amplified transduction
In addition to nanomaterials, functionalized magnetic particles have been commonly used for purposes such as manipulation of cells, (Xu et al. 2011 ) isolation of specific DNA molecules, (Fitzgerald and Grivel 2013) Raman, SPR. It is therefore not surprising that optical fibers were explored as an interesting platform for cytokine detection. (Huang et al. 2013b; Jeong et al. 2013) One of the published approaches was based on fiber-optic SPR for detection of IL-1, IL-6, and TNF-α in a buffered saline solution and a spiked cell culture medium. (Battaglia et al. 2005) In this study, the detection limit of IL-6 was reached to be 0.44 ng mL -1 . It has also been demonstrated that optical fiber based sensors has potential for real-time monitoring of biologically relevant molecules in complex biological fluids. A fiber-optic localized surface plasmon resonance sensor was fabricated for detection of IFN-γ using spherical AuNPs on a flattened end-face of optical fiber. (Jeong et al. 2013) The authors emphasized that the fabricated SPR sensor can be used for real-time label-free immunoassay, by the virtue of having a fast detection time (5 min), high resolution and sensitivity (2 pg mL -1 for IFN-γ).
Hairpin DNA probes based amplification strategy
Recently lots of research work on hairpin DNA probe based immunosensors for the ultrasensitive detection of biomarkers has been reported. (Ge et al. 2016; Gong et al. 2014; Guo et al. 2015; Yao et al. 2014; Zhang et al. 2014a; Zhang et al. 2014b ) This topic has been symmetrically reviewed. (Huang et al. 2015b) As an example, a hairpin 
Colour-coded beads
In high-throughput sensing technologies, the encoding microbeads and nanoprobes with a unique code is widely used to identify the attached ligand molecules. Blicharz and co-workers combined the advantage of microsphere based suspension array with the use of a fluorescence microscope for the analysis of inflammatory cytokines in saliva. ) The multiplexed antibody array in the study achieved simultaneous detection of ten cytokines associated with pulmonary inflammatory diseases in saliva. Only 100 μL sample was used and the total assay time was 2.5 h.
Another 
Sensor arrays
Color coded beads (suspension arrays) are popular choice for multiplex cytokine detection, but there are limitations on the number of distinguishable codes in the same array. To overcome this obstacle, a new encoding approach was developed by the combination of QD and magnetic NPs with nanosphere structure which ensures a greatly enlarged encoding capacity by tuning the magnetic field. (Song et al. 2014) This approach has applied to detection of IgG to demonstrate the reliability of NPs as encoded carriers in multiplex immunoassays. (Stoeva et al. 2006) The result is that
NPs conjugated with specific antibodies have bound only to the corresponding positive antigen immobilized on the substrate. In addition, the reproducibly obtained detection limit of IgG was low as 1 fM. The very bright and spectrally narrow NPs
Raman tags using SERS provide new opportunities for the optical encoding systems, and are expected to revolutionize high-throughput bioanalysis where multiplexing at high levels is needed. With tunable optical waveguides, silicon photonic MR has been demonstrated great potential for multiplex cytokine detection. (Sloan et al. 2013) In addition, using the multiplicative effects of optical resonant coupling to the PC in increasing the electric field intensity experienced by fluorescent labels and the spatially biased funneling of fluorophore emissions through coupling to PC resonances, PC enhanced fluorescence can be adapted to increase the sensitivity (pg mL -1 level) towards multiplex cytokine detection. (George et al. 2013) 7. Real time cytokine detection
Microfluidic system
Dynamic changes in analyte concentration are difficult to be measured in real time and in many cases this can only be done with special microfluidic devices. (Singhal et al. 2010 ) Microfluidic devices process volumes of fluids on the order of nanoliters and are capable to achieve multiplexing, automation, and high-throughput screening.
The coupling and integration of a sensing system in a microfluidic device has successfully been applied for real-time analysis with a small amount of sample. (Konry et al. 2013 ) Quasi-real time cytokine detection has been realized by combining immunoassays with a micro fluidic device. (Nie et al. 2014 ) For example, a simple lab-on-a-chip biosensor was developed to perform near real-time diagnostics of clinically relevant analytes such as cytokines and antibodies. (Cohen et al. 2015) In this work, the reagent volumes were reduced to 0.5 µL (nearly three orders of magnitude less than in a conventional assay), and the washing steps required in standard immunoassays were eliminated by the same chip. In addition, the detection process could be accomplished in seconds (nearly in real-time) in the flow through incubation channel.
In another example demonstration of this approach, IFN-γ released from an individual T-cell was detected by immunsensors integrated into a microfluidic chip. (Zhu et al. 2008) In this study, cell purification and cytokine detection were performed on the same microdevice which was able to significantly reduce the detection time to 1 h and sample blood volume 3 µL (Figure 7 ). The microfluidic chips are also compatible with multiplexing. For example a multi-analyte aptasensor for rapid detection of cytokines has been developed. In this study, IFN-γ was labeled with anthraquinonoid (AQ), and TNF-α was labeled with methylene blue (MB) redox reporters respectively. Once the cytokine conjugated with the corresponding aptamer, the now modified conformation of the aptamer resulted in decreased redox current.
These microfluidic devices were integrated with the aptasensor by standard soft lithography. The cytokines released from T-cells or monocytes were monitored on the same electrode by use of square wave voltammetry. 
Biochips
Designing suitable biochips is another approach to achieve dynamic and local monitoring of cytokine expression. This is an active area of research and recent trends in protein biochip technology has been reviewed. (Reddy Jr et al. 2015) Several groups are employing antibody-modified surfaces in conjunction with detection technologies, such as SPR to monitor cytokine secreted from cells in real time. (Milgram et al. 2011; Valentina et al. 2015) This is a promising direction for dynamic, label-free sensing, but the problem of expensive instrumentation will need to be addressed and detection of specific cell-secreted cytokines has yet to be demonstrated. In a few instances the biochip technology has been combined with the microfluidic system to realize the real time detection. (Jokerst et al. 2010) 
Practical considerations in cytokine immunosensing
For designing an immunosensing device, stability is a crucial factor besides the Reproducibility is another important property of a successful biosensor. Only a few studies focus on this topic for cytokine detection. (Agalliu et al. 2013; Hosnijeh et al. 2010 ) To our knowledge, the reported methods for cytokine immunosensing mostly concentrate on the increase in sensitivity and decreased sample volume but not on reproducibility, which might be due to the challenges of cytokine detection as we summarized in Figure 1 . Thus this review will not be able to satisfactorily cover this topic.
Commercial cytokine detection assays
A number of commercial cytokine kits based on different platforms are available and listed at Table S2 . Despite these active activities on cytokine kit development, the precision and reproducibility of these new approaches have not been well defined. In a study of multianalyte bead-based (Luminex) kits, the World Health Organization range and reproducibility were observed depending on the method used and even the cytokine detected, although Luminex-based kits were found to be highly reproducible and reliable. (Berthoud et al. 2011 ) Hence, the cytokine amount measured was critically influenced by the actual kit used. The quantitive determination of cytokines and therefore their use as biomarkers in serum samples have to be interpreted with specified conditions.
Conclusion and future perspectives
Cytokine immunosening approaches provide powerful tools for future of infectious disease diagnosis and drug screening. (Zhou et al. 2012 ) Hence, there is continuing demand for cytokine detection by immunosensing. The significant cytokine detection challenges can be met by designing functional sensing interfaces with improved performance. For example, engineering nanomaterials applied to the sensing interface or using surface enhancement techniques can greatly increase detection sensitivity.
Introducing monoclonal antibodies, aptamers, or anti-biofouling molecules to the sensing interface provides a pathway to improve selectivity. In addition, conjugation detection antibodies with different labels helps realize multiplex cytokine detection.
More importantly, it is possible to achieve real time cytokine detection by integrating microfluidic devices, new nanotechnology tools and different transducer methods. Moreover, aptamer based biosensors will be the next hot topic for cytokine detection because of their high stability, while aptamers against more cytokines will be required.
Therefore, research in the area of cytokine immunosensing is in its early stages, and will continue to grow. Its further development will have significant effect on cytokine biology and early diagnosis of a range of diseases.
